Table 3 Baseline characteristics of severely diseased P. ovale cases
Authors, year of publication | Age | Sex | Patient status | Travel history | Chemoprophylaxis |
|---|---|---|---|---|---|
Tomar et al. [61], 2015 | 75 | M | R | None, resident of India | NA |
Lemmerer et al. [62], 2015 | 29 | M | W | Democratic Republic of Congo | – |
Strydom et al. [36], 2014 | 42 | M | W | Guinea, Mozambique | None |
Rojo-Marcos et al. [24], 2014 | 17 | F | – | – | – |
31 | M | – | – | – | |
Lau et al. [8], 2013 | 59 | M | T | Nigeria | Mefloquine |
Hachimi et al. [42], 2013 | 31 | M | – | Democratic Republic of Congo | – |
Lahlou et al. [41], 2012 | 28 | M | W | Democratic Republic of Congo | – |
Roze et al. [63], 2011 | 24 | M | W | Chad, Ivory Coast | Doxycycline |
Coton et al. [64], 2011 | 33 | M | W | Djibouti | – |
Haydoura et al. [65], 2010 | 46 | F | B | NA | NA |
Cinquetti [66], 2010 | 34 | M | W | Ivory Coast, Senegal | Doxycycline |
Rojo-Marcos et al. [25], 2008 | 43 | M | V | Nigeria | None |
Rubinstein et al. [67], 2005 | 23 | M | – | Nigeria | – |
Filler et al. [68], 2003 | 39 | F | T | Cameroon, Botswana, Zimbabwe, South Africa | Yes, drug unknown |
Lee et al. [69], 1999 | 31 | F | T | Ghana | Mefloquine |
Patel [70], 1993 | 42 | M | T | Central and southern Africa | NA |
Facer et al. [9], 1991 | 51 | F | T | Ghana | None |
Monlun, et al. [71], 1989 | 38 | M | T | Niger | Chloroquine |
Bock [72], 1939 | 23 | – | W | Western Africa, Cameroon | Chinoplasmine |
20 | – | W | Western Africa, Cameroon | Quinine (irregular) | |
Fairley [73], 1933 | 28 | M | T | Nigeria, Ghana, Gambia, Sierra Leone | Quinine |